DIAN Dispatch From Hawaii: After Slow Start, Network Is Humming DIAN Dispatch from Hawaii: Glimpse at Data, Push for Trials The DIAN represents a bold attempt at pushing Alzheimer's clinical research squarely into the preclinical phase. It enrolls ad
Leaders of DIAN gathered to brief each other to present to some 30 pharmaceutical industry scientists the first cut of baseline data from this ongoing biomarker study...
After more than a year of rumbling to life, the Dominantly Inherited Alzheimer’s Network (DIAN) has kicked into gear and is now enrolling research participants at a healthy clip...
Scientists on an optimistic fishing expedition, involving 1,000 small molecules and hundreds of mice, have caught a big one with a chemical that promotes adult neurogenesis...
For research on age-related decline that hits closer to home, taxonomically and anatomically, check out two recent studies of rhesus monkeys in the Journal of Neuroscience...
Among the few genes recently linked to late-onset Alzheimer disease (LOAD) in multiple genomewide screens, clusterin has stolen the show in two new papers...
As denim trumps other fabrics in durability and longevity, genes may beat the pants out of diet and lifestyle in determining whether you’ll live to 100...
St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease.
It failed in the large Ginkgo of Memory (GEM) prevention trial, but companies are still betting ginkgo biloba extract is a valuable anti-dementia agent...